NeuroGlow is opening five no-cost IV ketamine treatment opportunities for North Texas veterans this Veterans Day. Clinical screening required.

I came to this kind of care as a patient first, at a point when I had run out of options, so this one is personal for me.”

— Reese Ormand, Co-Founder and CEO, NeuroGlow

FORT WORTH, TX, UNITED STATES, November 10, 2026 /EINPresswire.com/ — FORT WORTH, Texas, November 10, 2026. NeuroGlow, a Dallas-Fort Worth mental health practice led by a board-certified psychiatrist, is launching Operation Restore, its Veterans Treatment Initiative, for Veterans Day. The program is opening five no-cost IV ketamine treatment opportunities for U.S. military veterans seeking mental health care. Selected veterans who are medically cleared can receive an initial IV ketamine treatment series at no cost at NeuroGlow’s clinics in Fort Worth, McKinney and Flower Mound.

For many veterans, the challenges that follow service can continue long after coming home. In its 2026 National Veteran Suicide Prevention Annual Report, the U.S. Department of Veterans Affairs reported an average of 17.7 veteran suicides per day in 2024, and veterans continue to die by suicide at a markedly higher rate than other U.S. adults. Operation Restore was created to help a small group of veterans access another treatment option, delivered under medical supervision, when earlier approaches have not been enough. NeuroGlow is a private clinic and is not affiliated with or endorsed by the U.S. Department of Veterans Affairs.

“I came to this kind of care as a patient first, at a point when I had run out of options, so this one is personal for me,” said Reese Ormand, Co-Founder and CEO of NeuroGlow. “Too many veterans are fighting that same battle, and too many never get the chance to try another option. We cannot promise an outcome for anyone, but we can open the door, cover the cost, and make sure each selected veteran receives a careful clinical evaluation and, when it is appropriate, a full initial course of treatment.”

Operation Restore is overseen by Dr. Aaron Brown, DO, a psychiatrist and NeuroGlow’s Medical Director, and follows the same clinical standards as the practice’s self-pay program. At no cost to selected and medically cleared participants, the program covers the medical and psychiatric evaluation and intake appointments, an initial six-infusion IV ketamine series when clinically appropriate, and one integrative therapy session.

Applications are open to U.S. military veterans age 18 or older who can attend appointments in Fort Worth, McKinney or Flower Mound. Clinical screening is required, and a place in the program does not guarantee that treatment will be recommended. Veterans can learn more, review eligibility and apply at https://neuroglow.com/operation-restore/. Participation never requires a testimonial, review, photograph or social media post.

NeuroGlow’s initial goal is to welcome five selected veterans into care by the end of 2026, with treatment timing guided by each veteran’s clinical needs. The practice aims to expand Operation Restore to two additional veterans per month beginning in 2027, subject to program capacity and clinical eligibility.

Other Options for Veterans

Beyond Operation Restore, NeuroGlow offers additional paths for veterans. All veterans are eligible for the practice’s Hero Discount, which provides 20 percent off self-pay IV ketamine. NeuroGlow also offers Spravato, an FDA-approved esketamine nasal spray for certain forms of adult depression, which may be covered by insurance, including through TRICARE, CHAMPVA or VA Community Care. Coverage and any required authorization depend on each veteran’s plan and eligibility, and a separate clinical evaluation determines treatment eligibility.

Important Information About IV Ketamine

IV ketamine treatment for mental health conditions is off-label and is not FDA-approved for those conditions. Ketamine injection is FDA-approved as an anesthetic. Treatment requires evaluation by a licensed clinician, is not appropriate for everyone, and can cause side effects and serious risks, including sedation, dissociation (a feeling of disconnection from yourself or your surroundings), increased blood pressure and breathing problems. Ketamine is a Schedule III controlled substance with risks of abuse, misuse and dependence. Results vary and are not guaranteed.

If you are in crisis or having thoughts of suicide, call 988 or text 988 to reach the Suicide and Crisis Lifeline. If you are in immediate danger, call 911.

About NeuroGlow

NeuroGlow is a mental health practice led by a board-certified psychiatrist, offering IV ketamine therapy and Spravato (esketamine) across three Dallas-Fort Worth clinics in Fort Worth, McKinney and Flower Mound. NeuroGlow provides interventional psychiatric care for conditions including treatment-resistant depression, PTSD and anxiety, with treatment delivered under medical supervision. Learn more at https://neuroglow.com/

Media Relations
NeuroGlow
+1 469-218-4410
info@neuroglow.com
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
TikTok
X

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Media gallery

About The Author